Indiana Medicaid and GLP-1s

What changed, and what the document says

1. The Zepbound chapter says it in its title

   Not covered

   A heading is a strange place to put a coverage limit, and it is the clearest statement in the document.

   “ZEPBOUND (TIRZEPATIDE) (NOT COVERED EXCLUSIVELY FOR WEIGHT LOSS)”

   Prepared for State of Indiana by OptumRx — 10.01.2025

2. So does the Wegovy chapter

   Not covered

   The same construction, repeated, so neither reads as a one-off.

   “WEGOVY (SEMAGLUTIDE) (NOT COVERED EXCLUSIVELY FOR WEIGHT LOSS)”

   Prepared for State of Indiana by OptumRx — 10.01.2025

3. The rule has a code section behind it

   Not covered

   Indiana's pharmacy manual reproduces the administrative rule that excludes the category, so the criteria are downstream of a regulation.

   “Anorectics or any agent used to promote weight loss.”

   Indiana Health Coverage Programs (IHCP) — Published: Aug. 12, 2025; policies and procedures as of Feb. 1, 2025; Version 8.0

4. Children have a separate, older route

   Covered

   A bulletin that is still in the published index names two drugs available to eligible children with authorization.

   “Wegovy (semaglutide) and Saxenda (liraglutide)”

   Indiana Health Coverage Programs — IHCP bulletin BT2023148 — October 31, 2023

5. Reviewed twice a year

   Conditions apply

   The children's route is not open-ended; it is re-tested on a fixed cycle.

   “Reassessments of medical necessity for continued authorization will occur every six months.”

   Indiana Health Coverage Programs — IHCP bulletin BT2023148 — October 31, 2023

6. Who wrote the criteria

   Context

   Worth knowing when you read them: the document is authored by the state's pharmacy benefit manager on the state's behalf, and says so on its first page.

   “Prepared for State of Indiana by OptumRx”

   Prepared for State of Indiana by OptumRx — 10.01.2025

Which of these companies serve Indiana?

Of the 387 companies we grade, 34 publish a list of the states they are licensed in. We checked 251 more and found no such list on any page we read; 102 we have not checked either way.

23 of those lists name Indiana: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, Allara Health, MEDvidi, Gaya Wellness, and Mixx Health & Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.